Lista de obras - Carien L Creutzberg - Dominio Público Uruguay

A Controlled Study on Vaginal Blood Flow During Sexual Arousal Among Early-Stage Cervical Cancer Survivors Treated With Conventional Radical or Nerve-Sparing Surgery With or Without Radiotherapy

artículo científico publicado en 2017

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

artículo científico publicado en 2019

A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer

artículo científico publicado en 2016

Accuracy of patient positioning in mantle field irradiation

artículo científico publicado en 1992

Adjuvant Chemotherapy for Endometrial Cancer ⬇️

artículo científico publicado el 1 de octubre de 2010

Adjuvant Chemotherapy for Endometrial Cancer: Unproven ⬇️

artículo científico publicado el 1 de octubre de 2010

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

artículo científico publicado en 2020

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

artículo científico publicado en 2017

Appendix 5: Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org/Guidelines/Gynaecological-Cancers).

artículo científico publicado en 2017

Automated causal inference in application to randomized controlled clinical trials

artículo científico publicado en 2022

Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.

artículo científico publicado en 2017

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

artículo científico publicado en 2020

Cancer of the corpus uteri

scientific article published on 01 October 2012

Cancer of the corpus uteri.

artículo científico publicado en 2015

Chest wall irradiation with MLC-shaped photon and electron fields

artículo científico publicado en 2000

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

artículo científico publicado en 2014

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.

artículo científico publicado en 2017

Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma

scientific article published on 01 May 2006

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer

artículo científico publicado en 2010

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer

artículo científico publicado en 2007

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

artículo científico publicado en 2017

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

scientific article published on 18 December 2020

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up

artículo científico publicado en 2016

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases

artículo científico publicado en 2010

Electronic portal image assisted reduction of systematic set-up errors in head and neck irradiation

artículo científico publicado en 2001

Endometrial cancer

scientific article published on 06 September 2015

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies

artículo científico publicado en 2010

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

artículo científico publicado en 2016

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma

artículo científico publicado en 2011

Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data

artículo científico publicado en 2011

GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma?

scientific article published on 01 March 2004

Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.

artículo científico publicado en 2015

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.

artículo científico publicado en 2014

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

artículo científico publicado en 2020

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma

artículo científico publicado en 2014

High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging.

artículo científico publicado en 1996

Hyperbaric oxygen therapy for radiation-induced injury: evidence is needed

artículo científico publicado en 2015

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

artículo científico publicado en 2016

Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors.

artículo científico publicado en 2014

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.

artículo científico publicado en 2016

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

artículo científico publicado en 2012

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

artículo científico publicado en 2014

International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)

artículo científico publicado en 2010

International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia

artículo científico publicado en 2017

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy

artículo científico publicado en 2004

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results

artículo científico publicado en 2014

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

artículo científico publicado en 2017

Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer

artículo científico publicado en 2017

Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients.

artículo científico publicado en 2015

Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial

artículo científico publicado en 2015

Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy

artículo científico publicado en 2012

Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial

artículo científico publicado en 2011

Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.

artículo científico publicado en 2002

Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma.

artículo científico publicado en 2013

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

artículo científico publicado en 2013

Lymphadenectomy in apparent early-stage endometrial carcinoma: do numbers count?

scientific article published on 28 February 2005

Management of conjunctival melanoma with local excision and adjuvant brachytherapy

artículo científico publicado en 2020

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative

artículo científico publicado en 2017

Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer. ⬇️

artículo científico publicado en 2016

Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?

artículo científico publicado en 2018

Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor

artículo científico publicado en 1988

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials

artículo científico publicado en 2014

Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials

artículo científico publicado en 2015

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

artículo científico publicado en 2010

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

artículo científico publicado en 2003

On-line set-up corrections during radiotherapy of patients with gynecologic tumors.

artículo científico publicado en 2000

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

artículo científico publicado en 2004

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

artículo científico publicado en 2015

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

artículo científico publicado en 2020

PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER

artículo científico publicado en 2020

Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.

artículo científico publicado en 2016

Perceived information provision and satisfaction among lymphoma and multiple myeloma survivors—results from a Dutch population-based study ⬇️

artículo científico publicado el 26 de mayo de 2012

Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.

artículo científico

Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.

artículo científico publicado en 2018

Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study

scientific article published on 01 May 2006

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

artículo científico publicado en 2005

Practical guidance for mismatch repair-deficiency testing in endometrial cancer.

artículo científico publicado en 2016

Prediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parameters

artículo científico publicado en 2015

Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma

artículo científico publicado en 2004

Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.

artículo científico publicado en 2016

Prognostic significance of POLE proofreading mutations in endometrial cancer.

artículo científico publicado en 2014

Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).

artículo científico publicado en 2010

Psychosexual support for gynecological cancer survivors: professionals' current practices and need for assistance

artículo científico publicado en 2014

Qualitative accounts of patients' determinants of vaginal dilator use after pelvic radiotherapy

artículo científico publicado en 2014

Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial

artículo científico publicado en 2009

Radiation Treatment Affects Chromosome Testing in Uveal Melanoma

artículo científico publicado en 2015

Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial

artículo científico publicado en 2016

Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.

artículo científico publicado en 2008

Rectal bleeding after radiation therapy for endometrial cancer

artículo científico publicado en 2015

Reduction of irradiated small bowel volume and accurate patient positioning by use of a bellyboard device in pelvic radiotherapy of gynecological cancer patients

artículo científico publicado en 2001

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

artículo científico publicado en 2015

Reply to M. Wissing et al

artículo científico publicado en 2017

Results of the Australasian (Trans-Tasman Oncology Group) radiotherapy benchmarking exercise in preparation for participation in the PORTEC-3 trial.

artículo científico publicado en 2016

Risk factors and treatment for recurrent vulvar squamous cell carcinoma

artículo científico publicado en 2016

Ruthenium plaque radiation therapy for iris and iridociliary melanomas

artículo científico publicado en 2010

Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome

artículo científico publicado en 2016

Ruthenium-106 brachytherapy for iris and iridociliary melanomas

artículo científico publicado en 2017

Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptance†

artículo científico publicado en 2014

Second primary cancers in survivors of cervical cancer in The Netherlands: Implications for prevention and surveillance

artículo científico publicado en 2014

Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study.

artículo científico publicado en 2013

Sexual distress and associated factors among cervical cancer survivors: A cross-sectional multicenter observational study.

artículo científico publicado en 2016

Sexual dysfunction and infertility as late effects of cancer treatment

artículo científico publicado en 2014

Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method

artículo científico publicado en 2014

Sister Society Meeting on Global Education Development and Collaboration: Meeting Report

artículo científico publicado en 2016

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.

artículo científico publicado en 2015

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

artículo científico publicado en 2000

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

artículo científico publicado en 2003

Sweat production in children's feet

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

artículo científico publicado en 2022

The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial

artículo científico publicado en 2001

The role of radiotherapy in endometrial cancer: current evidence and trends

artículo científico publicado en 2011

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

artículo científico publicado en 2016

Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians.

artículo científico publicado en 2014

Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter?

artículo científico publicado en 2016

Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios

artículo científico publicado en 2015

Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?

scientific article published on 21 July 2016

[Is there an indication for additional local irradiation in conserving treatment of breast cancer patients aged 60 and over?]

artículo científico publicado en 2002

Lista de obras de Carien L Creutzberg

A Controlled Study on Vaginal Blood Flow During Sexual Arousal Among Early-Stage Cervical Cancer Survivors Treated With Conventional Radical or Nerve-Sparing Surgery With or Without Radiotherapy

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer

Accuracy of patient positioning in mantle field irradiation

Adjuvant Chemotherapy for Endometrial Cancer ⬇️

Adjuvant Chemotherapy for Endometrial Cancer: Unproven ⬇️

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma

Appendix 5: Endometrial cancer: eUpdate published online 8 June 2017 (www.esmo.org/Guidelines/Gynaecological-Cancers).

Automated causal inference in application to randomized controlled clinical trials

Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer

Cancer of the corpus uteri

Cancer of the corpus uteri.

Chest wall irradiation with MLC-shaped photon and electron fields

Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity

Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer.

Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases

Electronic portal image assisted reduction of systematic set-up errors in head and neck irradiation

Endometrial cancer

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma

Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data

GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma?

Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma

High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging.

Hyperbaric oxygen therapy for radiation-induced injury: evidence is needed

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors.

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.

Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy

International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)

International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia

Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer

Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: Results in 248 patients.

Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial

Long-term clinical outcome of patients with soft tissue sarcomas treated with limb-sparing surgery and postoperative radiotherapy

Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial

Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.

Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma.

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

Lymphadenectomy in apparent early-stage endometrial carcinoma: do numbers count?

Management of conjunctival melanoma with local excision and adjuvant brachytherapy

Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative

Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer. ⬇️

Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?

Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials

Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials

Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population.

Nuclear beta-catenin is a molecular feature of type I endometrial carcinoma.

On-line set-up corrections during radiotherapy of patients with gynecologic tumors.

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

PROGNOSTIC INTEGRATED IMAGE-BASED IMMUNE AND MOLECULAR PROFILING IN EARLY-STAGE ENDOMETRIAL CANCER

Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.

Perceived information provision and satisfaction among lymphoma and multiple myeloma survivors—results from a Dutch population-based study ⬇️

Persisting fatigue in Hodgkin lymphoma survivors: a systematic review.

Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.

Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.